What is Dualyx?
Headquartered in Belgium, Dualyx operates within the dynamic biotechnology sector, specializing in the development of novel immune modulators. The company's focus on this critical area of medical research positions it to address unmet needs in various therapeutic areas. The recent major strategic investment signifies a pivotal moment for Dualyx, likely enabling the acceleration of its research and development pipelines and the advancement of its lead candidates toward clinical trials and potential commercialization.
How much funding has Dualyx raised?
Dualyx has raised a total of $43.5M across 1 funding round:
Series A
$43.5M
Series A (2023): $43.5M with participation from Forbion, Andera, and Fountain Healthcare Partners
Key Investors in Dualyx
Forbion
Forbion is a leading European venture capital firm specializing in drug development and company building, known for its commitment to responsible investment and positive patient impact.
Andera
Andera, based in Maastricht, specializes in the restoration and sales of antique and classic cast iron design radiators, also offering related valves and bleed valves, and antique ceramic, cement, and terracotta floor tiles, as well as marble fireplaces and curios.
Fountain Healthcare Partners
Fountain Healthcare Partners is a venture fund providing risk capital and expertise to life sciences entrepreneurs, focusing on seed and early-stage companies in specialty pharma, biopharmaceuticals, medical devices, and diagnostics.
What's next for Dualyx?
The substantial enterprise-level backing and the recent strategic investment indicate that Dualyx is poised for significant expansion. This capital infusion is expected to fuel further research, enhance operational capabilities, and potentially broaden the company's therapeutic targets. The company's trajectory suggests a move towards scaling its operations and solidifying its position in the competitive biopharmaceutical landscape, with a clear focus on translating scientific innovation into tangible patient benefits.
See full Dualyx company page
